100 King St W, Suite 1600, 1 First Cdn Pl, Toronto, ON
Year called to bar: 1997 (ON)
Jason A. Saltzman is a partner in Gowling WLG's Toronto office practising corporate finance & securities law, with an emphasis on securities offerings, M&A, private equity/venture capital, and securities registration and compliance matters. Jason works with established and emerging issuers worldwide, primarily in the technology, cannabis, fintech, cleantech, life science, mining, media, sports/eSports, and entertainment sectors. He advises issuers, investment dealers, and institutional and private investors on equity and debt financing transactions, ranging from early stage, venture capital, and private equity investments to larger public offerings and project finance transactions. Jason has taken numerous companies public on the TSX, TSXV, and CSE by IPO, reverse takeover, capital pool transactions, and direct listings. He advises on corporate governance, disclosure obligations, securities issuances, hostile and friendly takeover bids, and proxy contests. He has built an alternative finance practice focusing on fin-tech, crowdfinance, and other disruptive models such as online investment platforms, cryptocurrencies, peer-to-peer lending, and robo-advising. He co-leads the Gowling WLG Israel Desk and has deep experience in assisting Israeli companies to go public in Canada.
On March 14, 2019, Aleafia Health Inc. (TSX: ALEF) completed its acquisition of Emblem Corp. (TSXV: EMC) by way of a plan of arrangement under the provisions of the Canada Business Corporations Act in an all share transaction valued at approximately $172.3 million at the time of the deal’s announcement. Pursuant to the arrangement, Aleafia acquired all of the common shares of Emblem, to form a new wholly-owned subsidiary continuing as “Emblem Corp.” Following the transaction, Aleafia graduated from the TSX Venture Exchange and commenced trading on the Toronto Stock Exchange.
Patheon Inc. completed a court-approved statutory plan of arrangement under the Canada Business Corporations Act under which Patheon was acquired for US$9.32 per share in cash resulting in a total enterprise value for Patheon of approximately US$1.98 billion.